Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak

Theratechnologies stock soars after $254 million acquisition deal

Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak

Offer of US$3.01 in cash plus one contingent value right for potential additional aggregate payments of up to US$1.19 per share Upfront and total potential cash con…

Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak

Offer of US$3.01 in cash plus one contingent value right for potential additional aggregate payments of up to US$1.19 per shareUpfront and total potential cash consideration represent respectively a 126% and 216% premium to Nasdaq closing price on date prior…

Theratechnologies Agrees To Be Taken Private By CB Biotechnology In $254 Mln Deal

(RTTNews) - Theratechnologies Inc. (THTX, TH.TO) has agreed to be taken private by CB Biotechnology, LLC, an affiliate of Future Pak, LLC, for US$3.01 per share in cash, plus one contingent value right or CVR per share. Each CVR entitles shareholders to potential additional cash

Theratechnologies Earnings Coming Next Week: Final Results Before Acquisition Closes

Last financial report before acquisition completion. No earnings call scheduled due to pending buyout. See how Theratechnologies performed in Q2 2025. Get details.

Theratechnologies shareholders should take the deal, Research Capital says

Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares to the proposed US$4.20 per share acquisition offer from CB Biotechnology, an affiliate of Future Pak. In a July 3 report, Uddin said the total offer, comprised of US$3.01 in cash and up to US$1.19 […] Source